US4375414A
(en)
*
|
1971-05-20 |
1983-03-01 |
Meir Strahilevitz |
Immunological methods for removing species from the blood circulatory system and devices therefor
|
US5919369A
(en)
*
|
1992-02-06 |
1999-07-06 |
Hemocleanse, Inc. |
Hemofiltration and plasmafiltration devices and methods
|
US5753227A
(en)
*
|
1993-07-23 |
1998-05-19 |
Strahilevitz; Meir |
Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
|
AUPN030794A0
(en)
|
1994-12-22 |
1995-01-27 |
Aruba International Pty Ltd |
Discontinuous plasma or serum delipidation
|
US7166295B1
(en)
*
|
1995-05-26 |
2007-01-23 |
Meir Strahilevitz |
Methods of treatment and diagnostic visualization, particularly in cancer
|
US5868936A
(en)
*
|
1996-06-20 |
1999-02-09 |
Baxter International Inc. |
Affinity membrane system and method of using same
|
CA2214754A1
(en)
*
|
1996-09-09 |
1998-03-09 |
Masataka Narisada |
Method and apparatus for treating blood
|
US6245038B1
(en)
*
|
1997-01-07 |
2001-06-12 |
Helmut Borberg |
Method for treatment of ophthalmological diseases
|
US6627151B1
(en)
*
|
1997-06-13 |
2003-09-30 |
Helmut Borberg |
Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion
|
US20020198487A1
(en)
*
|
2001-04-10 |
2002-12-26 |
Renal Tech International |
Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids
|
US20020197250A1
(en)
*
|
2001-04-10 |
2002-12-26 |
Renal Tech International |
Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
|
US8329388B2
(en)
*
|
1997-07-30 |
2012-12-11 |
Cytosorbents, Inc. |
Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood
|
US20020197249A1
(en)
*
|
2001-04-10 |
2002-12-26 |
Renal Tech International |
Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products
|
US20020159995A1
(en)
*
|
1997-07-30 |
2002-10-31 |
Renal Tech International |
Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
|
US8197430B1
(en)
|
1998-05-22 |
2012-06-12 |
Biopheresis Technologies, Inc. |
Method and system to remove cytokine inhibitor in patients
|
US6620382B1
(en)
|
1998-05-22 |
2003-09-16 |
Biopheresis Technologies, Llc. |
Method and compositions for treatment of cancers
|
US6287516B1
(en)
|
1998-07-10 |
2001-09-11 |
Immunocept, L.L.C. |
Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
|
US20040199099A1
(en)
*
|
1998-07-10 |
2004-10-07 |
Matson James R |
Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
|
AU2830400A
(en)
*
|
1999-03-05 |
2000-09-28 |
Mitsubishi Rayon Company Limited |
Carriers having biological substance
|
WO2000066198A1
(en)
*
|
1999-04-30 |
2000-11-09 |
Hemex, Inc. |
Method for removing heavy metals from bone
|
WO2000074824A1
(en)
*
|
1999-06-03 |
2000-12-14 |
Advanced Extravascular Systems |
One step removal of unwanted molecules from circulating blood
|
US6464976B1
(en)
|
1999-09-07 |
2002-10-15 |
Canji, Inc. |
Methods and compositions for reducing immune response
|
US6379708B1
(en)
*
|
1999-11-20 |
2002-04-30 |
Cytologic, Llc |
Method for enhancing immune responses in mammals
|
US7291122B2
(en)
*
|
2000-03-24 |
2007-11-06 |
Immunocept, L.L.C. |
Hemofiltration methods for treatment of diseases in a mammal
|
US6736972B1
(en)
|
2000-03-24 |
2004-05-18 |
Immunocept, L.L.C. |
Method and system for providing therapeutic agents with hemofiltration for reducing inflammatory mediator related diseases
|
AU2001259469A1
(en)
*
|
2000-05-05 |
2001-11-20 |
Hemocleanse, Inc. |
Use of magnetic particles or other particles having relatively high density in afluid for mixing and/or leak detection
|
US8865172B2
(en)
|
2000-05-08 |
2014-10-21 |
Advanced Extravascular Systems, Inc. |
Method for reducing the number of unwanted molecules in bodily fluids
|
US6787040B2
(en)
*
|
2000-05-16 |
2004-09-07 |
Immunocept, L.L.C. |
Method and system for colloid exchange therapy
|
US7439052B2
(en)
*
|
2000-06-29 |
2008-10-21 |
Lipid Sciences |
Method of making modified immunodeficiency virus particles
|
US7407663B2
(en)
|
2000-06-29 |
2008-08-05 |
Lipid Sciences, Inc. |
Modified immunodeficiency virus particles
|
US7407662B2
(en)
*
|
2000-06-29 |
2008-08-05 |
Lipid Sciences, Inc. |
Modified viral particles with immunogenic properties and reduced lipid content
|
US20090017069A1
(en)
*
|
2000-06-29 |
2009-01-15 |
Lipid Sciences, Inc. |
SARS Vaccine Compositions and Methods of Making and Using Them
|
AUPQ846900A0
(en)
*
|
2000-06-29 |
2000-07-27 |
Aruba International Pty Ltd |
A vaccine
|
ATE291580T1
(de)
*
|
2000-09-12 |
2005-04-15 |
Max Planck Gesellschaft |
Hochtemperaturstabile siliciumborcarbidnitridkeramiken aus silylalkylborazinen, verfahren zu deren herstellung sowie deren verwendung
|
GB0103766D0
(en)
*
|
2001-02-15 |
2001-04-04 |
Affitech As |
Diagnostic
|
US6706008B2
(en)
|
2001-03-06 |
2004-03-16 |
Baxter International Inc. |
Automated system and method for withdrawing compounds from blood
|
US6582386B2
(en)
|
2001-03-06 |
2003-06-24 |
Baxter International Inc. |
Multi-purpose, automated blood and fluid processing systems and methods
|
US6884228B2
(en)
|
2001-03-06 |
2005-04-26 |
Baxter International Inc. |
Automated system adaptable for use with different fluid circuits
|
US6878127B2
(en)
*
|
2001-04-10 |
2005-04-12 |
Renaltech International, Llc |
Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
|
US20020197252A1
(en)
*
|
2001-04-10 |
2002-12-26 |
Renal Tech International |
Selective adsorption devices and systems
|
US20030104350A1
(en)
*
|
2001-06-25 |
2003-06-05 |
Bomberger David C. |
Systems and methods using a solvent for the removal of lipids from fluids
|
US6991727B2
(en)
*
|
2001-06-25 |
2006-01-31 |
Lipid Sciences, Inc. |
Hollow fiber contactor systems for removal of lipids from fluids
|
US20060060520A1
(en)
*
|
2001-06-25 |
2006-03-23 |
Bomberger David C |
Systems and methods using a solvent for the removal of lipids from fluids
|
US7033500B2
(en)
*
|
2001-06-25 |
2006-04-25 |
Lipid Sciences, Inc. |
Systems and methods using multiple solvents for the removal of lipids from fluids
|
FR2826975B1
(fr)
*
|
2001-07-09 |
2004-06-04 |
Bio Merieux |
Utilisation de lipoproteines oxydees pour obtenir la differenciation de monocytes en cellules dendritiques matures
|
WO2003012396A2
(en)
*
|
2001-08-01 |
2003-02-13 |
Chauhan Anil K |
Immune complexes
|
US7569025B2
(en)
*
|
2002-04-02 |
2009-08-04 |
Scantibodies Laboratory, Inc. |
Methods and devices for treating severe peripheral bacterial infections
|
US7211258B2
(en)
*
|
2002-04-10 |
2007-05-01 |
Protalex, Inc. |
Protein A compositions and methods of use
|
US7425331B2
(en)
*
|
2002-04-10 |
2008-09-16 |
Protalex, Inc. |
Protein A methods of use
|
EP1507557A4
(de)
*
|
2002-04-23 |
2006-06-14 |
Meir Strahilevitz |
Verfahren und vorrichtungen zum anzielen eines situs in einem säugetier und zur entfernung von spezies aus einem säugetier
|
US7455771B2
(en)
*
|
2002-05-14 |
2008-11-25 |
Hepa Wash Gmbh |
Means for removing protein-bound substances
|
EP1362605A1
(de)
*
|
2002-05-14 |
2003-11-19 |
Bernhard Dr. Kreymann |
Dialysevorrichtung zur Entfernung proteingebundener Substanzen
|
AU2003251567A1
(en)
*
|
2002-06-19 |
2004-01-06 |
The Board Of Regents Of The University Of Texas System |
Dialysis system for treatment of vulnerable patients and methods of use
|
BRPI0313399A2
(pt)
*
|
2002-08-13 |
2016-11-08 |
Arbios Technologies Inc |
terapia de troca de plasma seletiva
|
KR100459432B1
(ko)
*
|
2002-08-21 |
2004-12-03 |
엘지전자 주식회사 |
이동통신 시스템의 핸드오버 처리방법
|
CA2496831A1
(en)
*
|
2002-08-26 |
2004-03-04 |
Lipid Sciences, Inc. |
Treating alzheimers using delipidated protein particles
|
BR0315942A
(pt)
*
|
2002-11-27 |
2005-10-04 |
Dmi Biosciences Inc |
Tratamento de doenças e condições mediadas pelo aumento de fosforilação
|
WO2004071446A2
(en)
*
|
2003-02-12 |
2004-08-26 |
Chauhan Anil K |
Immune complexes
|
US20040186407A1
(en)
*
|
2003-03-17 |
2004-09-23 |
Kimberly Walker |
Concentrator and filter apparatus for treatment of blood
|
US20040185041A1
(en)
*
|
2003-03-17 |
2004-09-23 |
Henna Vation, Llc |
Method for extracorporeal treatment of blood
|
US20040185426A1
(en)
*
|
2003-03-17 |
2004-09-23 |
Mallett Scott R. |
Ultraviolet light and filter apparatus for treatment of blood
|
US20040186412A1
(en)
*
|
2003-03-17 |
2004-09-23 |
Mallett Scott R. |
Extracorporeal blood treatment system using ultraviolet light and filters
|
US7201730B2
(en)
|
2003-03-17 |
2007-04-10 |
Hemavation, Llc |
Device and method for reducing inflammatory mediators in blood
|
US7207964B2
(en)
*
|
2003-03-17 |
2007-04-24 |
Hemavation, Llc |
Apparatus and method for down-regulating immune system mediators in blood
|
US7229427B2
(en)
*
|
2003-03-17 |
2007-06-12 |
Hemavation |
Irradiation and filter device for treatment of blood
|
US20040182784A1
(en)
*
|
2003-03-17 |
2004-09-23 |
Walker Kimberly A. |
Concentrator and filter based blood treatment system
|
US20040182783A1
(en)
*
|
2003-03-17 |
2004-09-23 |
Walker Kimberly A. |
Filter and concentrator device for treatment of blood
|
WO2005030119A2
(en)
*
|
2003-04-11 |
2005-04-07 |
Allergan, Inc. |
Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
|
US20080171347A1
(en)
*
|
2003-04-11 |
2008-07-17 |
Atassi M Zouhair |
Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
|
PT1641421T
(pt)
*
|
2003-07-03 |
2019-03-27 |
Hdl Therapeutics Inc |
Métodos e dispositivos para criar derivados de partículas de hdl com conteúdo de lípidos reduzido
|
US7393826B2
(en)
*
|
2003-07-03 |
2008-07-01 |
Lipid Sciences, Inc. |
Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
|
US6960803B2
(en)
*
|
2003-10-23 |
2005-11-01 |
Silicon Storage Technology, Inc. |
Landing pad for use as a contact to a conductive spacer
|
CN2698358Y
(zh)
*
|
2004-04-06 |
2005-05-11 |
上海江夏血液技术有限公司 |
血液过滤装置
|
JP2007532687A
(ja)
*
|
2004-04-26 |
2007-11-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
フェキソフェナジン塩酸塩の結晶形およびその製造方法
|
PT1949915E
(pt)
*
|
2004-04-30 |
2012-11-27 |
Biopheresis Technologies Inc |
Método e sistema para remover rfnt1,rfnt2, e ril2 solúveis em pacientes
|
KR101290558B1
(ko)
*
|
2004-07-30 |
2013-07-31 |
퓨리셀렉트 게엠베하 |
생물학적 연구를 포함하는 생명공학 및 의약적 진단학에서,동물에의 적용을 목적으로, 체액으로부터 세포, 생체 입자및/또는 분자를 분리하는 장치 및 방법
|
US8080245B2
(en)
|
2004-08-04 |
2011-12-20 |
University Of Massachusetts |
Anti-pathogen immunoadhesins
|
US20060068454A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Sysmex Corporation |
Method of inactivating blood coagulation factor and blood coagulation factor-inactivated sample
|
WO2006042149A2
(en)
*
|
2004-10-06 |
2006-04-20 |
Allergan, Inc. |
Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
|
US7569353B2
(en)
*
|
2004-11-04 |
2009-08-04 |
Quest Diagnostics Investments Incorporated |
Myeloperoxidase detection in diagnosis and prognosis of hematopoietic disorders
|
US20060147536A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Fiore Robert A |
Method for removing fluids containing dissolved or suspended carbohydrates, lipids, metals, salts, and/or toxins from biological systems
|
EP1951336A2
(de)
*
|
2005-07-18 |
2008-08-06 |
The Trustees Of Boston University |
Verfahren zur hemmung der proliferation und des wachstums von metastasen
|
US20070065514A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Howell Mark D |
Method for enhancing immune responses in mammals
|
AU2006325531B2
(en)
|
2005-12-13 |
2012-04-19 |
Exthera Medical Corporation |
Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
|
DE102006012024A1
(de)
*
|
2006-03-14 |
2007-09-20 |
Adexter Gmbh |
Regenerierbares Filter zur extrakorporalen Behandlung partikelhaltiger Flüssigkeiten und deren Anwendung
|
US7855268B2
(en)
*
|
2006-06-01 |
2010-12-21 |
Allergan, Inc. |
Tolerogizing compositions comprising botulinum toxin type B peptides
|
US7670788B2
(en)
*
|
2006-06-01 |
2010-03-02 |
Allergan, Inc. |
Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides
|
EP2077869B1
(de)
*
|
2006-08-28 |
2015-02-25 |
Akademia Medyczna Im. Piastow Slaskich We Wroclaw iu |
System zur extrakorporalen reinigung von blut von pathogenen enzymen
|
US20100176051A1
(en)
|
2006-08-31 |
2010-07-15 |
Toray Industries, Inc., A Corporation Of Japan |
Adsorption carrier containing composite fiber
|
US20080075690A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Mark Douglas Howell |
Method for enhancing immune responses in mammals
|
US8211310B2
(en)
|
2006-11-20 |
2012-07-03 |
Cytosorbents, Inc. |
Size-selective polymer system
|
US7875182B2
(en)
*
|
2006-11-20 |
2011-01-25 |
Cytosorbents, Inc. |
Size-selective hemoperfusion polymeric adsorbents
|
US9604196B2
(en)
|
2006-11-20 |
2017-03-28 |
Cytosorbent, Inc. |
Size-selective hemocompatible polymer system
|
EP2002855B1
(de)
*
|
2007-06-14 |
2012-07-11 |
RenApta B.V. |
Künstliche Niere
|
WO2009096851A1
(en)
*
|
2008-01-28 |
2009-08-06 |
Milux Holding Sa |
A drainage device comprising a filter cleaning device
|
US8454547B2
(en)
*
|
2009-02-25 |
2013-06-04 |
The Invention Science Fund I, Llc |
Device, system, and method for controllably reducing inflammatory mediators in a subject
|
US8317737B2
(en)
*
|
2009-02-25 |
2012-11-27 |
The Invention Science Fund I, Llc |
Device for actively removing a target component from blood or lymph of a vertebrate subject
|
US8167871B2
(en)
|
2009-02-25 |
2012-05-01 |
The Invention Science Fund I, Llc |
Device for actively removing a target cell from blood or lymph of a vertebrate subject
|
WO2010107789A1
(en)
*
|
2009-03-17 |
2010-09-23 |
Marv Enterprises Llc |
Sequential extracorporeal treatment of bodily fluids
|
WO2011068897A1
(en)
|
2009-12-01 |
2011-06-09 |
Exthera Medical, Llc |
Method for removing cytokines from blood with surface immobilized polysaccharides
|
AU2010341703B2
(en)
*
|
2009-12-08 |
2016-01-21 |
The Board Of Trustees Of The University Of Illinois |
Stem cell immune modulation methods of use and apparatus
|
US20110295175A1
(en)
*
|
2010-03-16 |
2011-12-01 |
Marv Enterprises Llc |
Sequential Extracoporeal Treatment of Bodily Fluids
|
WO2012112724A1
(en)
|
2011-02-15 |
2012-08-23 |
Exthera Medical, Llc |
Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
|
EP3184131B1
(de)
|
2011-04-13 |
2022-05-04 |
Fenwal, Inc. |
Zentrifugiersystem mit erythrozytenbarriere
|
CN103476484B
(zh)
|
2011-04-13 |
2016-11-09 |
汾沃有限公司 |
用于使用和控制具有吸附柱的自动分离器的系统和方法
|
WO2013028451A1
(en)
*
|
2011-08-19 |
2013-02-28 |
Marv Enterprises |
Method for the treatment of cancer
|
US20140251917A1
(en)
*
|
2011-09-22 |
2014-09-11 |
Marv Enterprises,LLC |
Method for the treatment of multiple sclerosis
|
SE1200356A1
(sv)
|
2011-10-30 |
2013-05-01 |
Kurt Nilsson |
Polymerbaserad produkt och användning
|
WO2013148405A2
(en)
*
|
2012-03-27 |
2013-10-03 |
Felder Mitchell S |
Treatment for atherosclerosis
|
WO2013177096A1
(en)
*
|
2012-05-22 |
2013-11-28 |
Felder Mitchell S |
A method for the treatment of cancer
|
US20150071935A1
(en)
*
|
2012-05-27 |
2015-03-12 |
Marv Enterprises, LLC |
Treatment for the rapid amelioration of clinical depression
|
DK2861273T3
(da)
*
|
2012-06-13 |
2017-11-27 |
Exthera Medical Corp |
Anvendelse af heparin og kulhydrater til behandling af cancer.
|
US9717841B2
(en)
|
2012-09-11 |
2017-08-01 |
Gary L. McNeil |
Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
|
JP6648009B2
(ja)
|
2013-06-24 |
2020-02-14 |
エクステラ・メディカル・コーポレーション |
マンノース被覆基材を含有する血液濾過システム
|
MX2016005959A
(es)
|
2013-11-08 |
2016-10-14 |
Exthera Medical Corp |
Métodos para diagnosticar enfermedades infecciosas usando medio de adsorción.
|
BR112016024569B1
(pt)
|
2014-04-24 |
2023-01-03 |
Exthera Medical Corporation |
Método ex vivo para remover bactérias de uma amostra retirada de um indivíduo que é suspeito de estar infectado com a mesma
|
US20170065717A1
(en)
*
|
2014-05-06 |
2017-03-09 |
Marv Enterprises, LLC |
Method for treating muscular dystrophy
|
EP2987512B1
(de)
|
2014-08-21 |
2017-03-22 |
Fenwal, Inc. |
Parallelverarbeitung von flüssigkeitsbestandteilen
|
MX2017003723A
(es)
|
2014-09-22 |
2017-06-30 |
Exthera Medical Corp |
Dispositivo de hemoperfusion portatil.
|
US10975131B2
(en)
|
2015-10-27 |
2021-04-13 |
University Of Massachusetts |
Factor H-Fc immunotheraphy
|
WO2017084683A1
(en)
|
2015-11-20 |
2017-05-26 |
Hepa Wash Gmbh |
Method for extracorporeal lung support
|
WO2017084682A1
(en)
|
2015-11-20 |
2017-05-26 |
Hepa Wash Gmbh |
Method for extracorporeal carbon dioxide removal
|
US11383015B2
(en)
|
2016-01-11 |
2022-07-12 |
Fenwal, Inc. |
System and method for plasma purification prior to mononuclear cell collection
|
EP3422943A4
(de)
|
2016-03-02 |
2019-10-16 |
ExThera Medical Corporation |
Verfahren zur behandlung von arzneimittelintoxikation
|
US11911551B2
(en)
|
2016-03-02 |
2024-02-27 |
Exthera Medical Corporation |
Method for treating drug intoxication
|
PL3429657T3
(pl)
|
2016-03-14 |
2022-08-22 |
Advitos Gmbh |
Systemy albo aparatury dla przeprowadzania dializy
|
US10858422B2
(en)
|
2016-05-31 |
2020-12-08 |
Abcentra, Llc |
Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
|
WO2017210360A1
(en)
|
2016-05-31 |
2017-12-07 |
Cardiovax, Llc |
Methods for diagnosing and treating systemic lupus erythematosus
|
HUE064189T2
(hu)
|
2016-07-28 |
2024-02-28 |
Captec Medical Kft |
Áramlásból befogó eszköz sejtek vérbõl történõ eltávolítására
|
KR20200011461A
(ko)
|
2017-05-22 |
2020-02-03 |
아드비토스 게엠베하 |
이산화탄소 제거 방법 및 시스템
|
CN111868232A
(zh)
|
2017-11-22 |
2020-10-30 |
Hdl治疗公司 |
用于对血浆处理系统的流体回路进行灌注的系统和方法
|
CA3087207A1
(en)
|
2017-12-28 |
2019-07-04 |
Hdl Therapeutics, Inc. |
Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
|
ES2722802B2
(es)
*
|
2018-02-14 |
2019-12-18 |
Fund De Neurociencias |
Dispositivo para la eliminacion selectiva de moleculas de tejidos o fluidos
|
FR3091999A1
(fr)
*
|
2019-01-25 |
2020-07-31 |
Mexbrain |
Dispositif d’extraction conjointe d’un cation métallique et d’une molécule cible
|
CN113795270A
(zh)
*
|
2019-02-26 |
2021-12-14 |
质量基因国际公司 |
从全血移除目标对象的全血处理装置和方法
|
EP3705146A3
(de)
|
2019-03-05 |
2020-11-25 |
Fenwal, Inc. |
Entnahme von mononukleären zellen und peripheren blutstammzellen
|
JP2023544347A
(ja)
|
2020-10-01 |
2023-10-23 |
イミューニコム, インコーポレイテッド |
リガンドの浸出の低減
|
US11224858B1
(en)
|
2020-10-01 |
2022-01-18 |
Immunicom, Inc. |
Reduced leaching of a ligand
|
ES2940917B2
(es)
*
|
2023-02-22 |
2023-11-30 |
Tecnic Biotech S L |
Un filtro de aféresis y un método para la eliminación de platino residual en sangre
|